Skip to Main Content

Paper Details

Is more better? Increased doses of high dose methotrexate and addition of rituximab is associated with improved outcomes in a large primary CNS lymphoma cohort.
Ann Lymphoma
1
2023
Author NameAffiliation
Katherine S PanageasMemorial Sloan Kettering Cancer Center
  • 1 - 1

Datasets

Release 1.2